Article
Extracellular Matrix-Induced Genes May Reduce Response to Rapamycin in LAM
2024-05-19
Abstract excerpt
<h4>Rationale</h4> Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease driven by nodules containing TSC2 -/- ‘LAM cells’ and recruited LAM associated fibroblasts (LAFs). Although rapamycin reduces lung function loss, some patients continue to decline meaning additional therapies are needed. <h4>Objectives</h4> To investigate how the LAM nodule environment affects LAM cell proliferation and the respons...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1cb7e0f8-f548-517f-95db-c5a909c6185d
- DOI
- 10.1101/2024.05.16.594484
